Conditions for Applicants for GSK Awards

 

Applications must be completed in English.

  • Abbreviations should not be used in the application unless fully explained.
  • The outcome of the selection of funded proposals will be final, binding and not open to appeal.
  • The grant can be used to fund direct costs related to the project only, which includes costs for equipment, field work and data collection, consumables and research assistance, travel to conferences, subsistence and conference fees.
  • Institutions may request overhead costs, not exceeding 8% of direct costs.
  • The principal applicant’s institution will be responsible for the receipt and administration of all funds.
  • All costs must be reasonable and justified and will ultimately be awarded at the discretion of GSK.
  • The grant can only be used to deliver the objectives stated in the grant application.
  • The grant may be used to contract out elements of the work where required. However the grantee is not permitted to make sub-grants.
  • The maximum term of the grant is three years from the date of the agreement being signed.  There is no minimum term.
  • Grants of up to £750,000 will be made.
  • Grants are made on the basis that the grantee commits to conduct all work to the relevant applicable global standard including but not limited to: Declaration of Helsinki, ICH GCP, ICH GMP and all locally relevant regulations.
  • Approved grants will have funds released in stages as required, in response to successful completion of prior stages of research and achievement of milestones.
  • Grantees must maintain transparent, adequate records to track use of the funds provided and the results recorded from the research.
  • Grantees are expected to publish research findings in quality peer-reviewed journals.
  • Applications will only be accepted from research teams led from Cameroon, Cote D’Ivoire, Ethiopia, Ghana, Gambia, Kenya, Malawi, Nigeria, Senegal, South Africa, Tanzania & Uganda. However, collaborations with centres outside of the applicant’s country but within sub-Saharan Africa are encouraged.
  • Each applicant can only submit one application. Multiple applications can however, be submitted by an institution.
  • Applications must be for work programmes that are lawful in the countries in which the work will be carried out.
  • Depending on the intellectual contribution associated with the proposal, successful grantees will be expected to sign a collaboration agreement with GSK which will be based on the relevant Lambert Agreement (or similar), as described at http://www.ipo.gov.uk/Lambert, with the further intention that results of the collaboration are shared for the broader benefit of the research community.
  • Applications must not be submitted for research, which would breach the intellectual property rights of other parties.